Skip to content
Company Analysis

Inspire Medical Systems, Inc. INSP

A comprehensive view of key metrics, scores, and financial health for Inspire Medical Systems, Inc.

Overview of Inspire Medical Systems, Inc.

INSP NYQ
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Small Cap
Inspire Medical Systems, Inc. (INSP), is a Small Cap company, in the Medical Devices industry, last closed at $67.21, about 27.9% overvalued vs fair value, -19.8% 1Y return, ranked 397/1145 in sector.
Metrics P/E 18.9× Rev Growth 13.6% ROE 19.8% Gross Margin 85.4%
USD 67.21
-1.31%
(Delayed)
• Vol 90d: 56.5%
52-Week Range
Market Cap
$1.94B
Enterprise Value
$1.82B
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Good
Health
Good
Efficiency
Good
Valuation
Fair
Growth
Fair
Profitability
Good
Health
Good
Efficiency
Good
Valuation
Fair
Completeness: 82%
Confidence: 90%
Updated: Oct 31
Top Beats

Quick Facts

Website https://www.inspiresleep.com
HQ Golden Valley, MN
Employees 1,333
Fiscal year Dec 31

Next Events

Earnings Nov 2 Call: Nov 2

Fair Value Snapshot

Bear Base Bull
$43
$48
$55
Current: $67.21 -28% vs base

Engine Room Money Flow™

Small Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$912.0M
13.6%%
Gross Profit
$778.8M
14.6%%
Operating Income (GAAP)
$51.0M
41.2%%
EBITDA
$79.8M
22.7%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
85.4%
Excellent

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$175.0M
223.0% of Free Cash Flow

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
3
Active Leaks
3/3
Improving
0
High Impact
3
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Inspire Medical Systems, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
73
/100
Moderate
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Elite Gross Margins Gross margin quality is top-tier vs peers (score 0.93). This signals strong consumable attach-rate economics.
  • Superior Capital Returns Capital return quality is top-tier (score 0.80). High ROIC indicates the business is reinvesting at attractive rates.

Key risks

  • Thin Interest Coverage Interest coverage lags peers (score 0.27). Thin coverage limits M&A optionality and raises refinancing risk.
  • Revenue Growth Slowing Revenue growth trend is weak (score 0.20). Slowing top-line momentum reduces the future consumable base.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Strong
93
Premium

Signals, strengths and risks for Pricing Power & Consumable Moat

Premium

Signals, strengths and risks for R&D Pipeline & Capital Returns

Premium

Signals, strengths and risks for FCF Quality & Cash Conversion

Premium

Signals, strengths and risks for Commercial Execution

Premium

Signals, strengths and risks for Capital Structure & Resilience

Premium

Signals, strengths and risks for Growth Durability

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 92% Coverage
Trade-Off Triangle Visualization A ternary plot showing INSP's balance between Growth (35.5%), Profitability (36.1%), and Safety (28.4%). Growth 36% Safety 28% Profitability 36%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

78th percentile vs peers
79
Key Signals
Rev Growth YoY 13.6% 64p EPS Growth YoY 1.72 95p Revenue CAGR 3Y 30.8% 83p Asset Growth YoY 12.2% 75p
Strengths
  • EPS Growth YoY in top 20% of peers (1.72, 95th percentile)
  • Revenue CAGR 3Y in top 20% of peers (30.8%, 83th percentile)
  • Gross Profit Margin in top 20% of peers (85.4%, 94th percentile)
  • Superior capital returns - 2 return metrics above peer median
  • Growth above peer median with strong metric coverage (75%)
Risks

No significant risks identified for this axis.

Profitability

79th percentile vs peers
80
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

63th percentile vs peers
63
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Inspire Medical Systems, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$48.45
- - -
-27.9% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000